Implant-associated infections: An overview

Journal of Long-Term Effects of Medical Implants

Volumn 16, Issue 1, 2006, Pages 83-99

  Hedrick, T L ^a,b   Adams, J D ^a   Sawyer, R G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antibiotics; Implants; Prophylaxis; Treatment

Indexed keywords

ANTIBIOTICS; BIOMATERIALS; DENTAL MATERIALS; DIAGNOSIS; EPIDEMIOLOGY; MEDICAL PROBLEMS; NEUROSURGERY; PATIENT TREATMENT; PHYSIOLOGY;

INFECTIONS; MANDATES; MEDICAL COMMUNITY; PROPHYLAXIS;

DENTAL PROSTHESES;

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BACITRACIN; CEFAMANDOLE; CEFAZOLIN; CEFONICID; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; HYDROGEN PEROXIDE; LINEZOLID; METRONIDAZOLE; MINOCYCLINE; NAFCILLIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; BIOFILM; BRAIN VENTRICLE PERITONEUM SHUNT; BREAST ENDOPROSTHESIS; CLINICAL TRIAL; COCHLEA PROSTHESIS; DEBRIDEMENT; DEVICE REMOVAL; DISINFECTION; DRUG EFFICACY; HUMAN; IMPLANT; INCIDENCE; MOUTH HYGIENE; ORTHOPEDIC EQUIPMENT; PENIS PROSTHESIS; PROSTHESIS INFECTION; PROSTHETIC MESH; REIMPLANTATION; REVIEW; SURGICAL DRAINAGE; TOOTH PROSTHESIS;

EID: 33645473780     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v16.i1.90     Document Type: Review

References (87)

1. Irish JD. A 5,500 year old artificial human tooth from Egypt: a historical note. Int J Oral Maxillofac Implants. 2004;19(5):645-7.
2. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422-9.
3. Zobell C. The effect of solid surfaces upon bacterial activity. J Bacteriol. 1943;46:39-56.
4. Habash M RG. Microbial Biofilms: Their development and significance for medical device-related infections. J Clin Pharm. 1999;39:887-98.
5. Collaboration EH. Mesh compared with non-mesh methods of open groin hernia repair: systematic review of randomized controlled trials. Br J Surg. 2000;87(7):854-9.
6. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 2004;240(4):578-83; discussion 583-5.
7. Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet. 2001;358(9285):876-80.
8. Deysine M. Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. Surg Clin North Am. 1998;78(6):1105-15, viii.
9. Mann DV, Prout J, Havranek E, Gould S, Darzi A. Late-onset deep prosthetic infection following mesh repair of inguinal hernia. Am J Surg. 1998;176(1):12-4.
10. Celdran AFO, de la Pinta JC, Souto JL, Esteban J, Rubio JM, Senaris JF. The role of antibiotic prophylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis. Hernia. 2004;8:20-2.
11. Platt R, Zaleznik DF, Hopkins CC, Dellinger EP, Karchmer AW, Bryan CS, Burke JF, Wilder MA, Marino SK, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med. 1990;322(3):153-60.
12. Lazorthes F, Chiotasso P, Massip P, Materre JP, Sarkissian M. Local antibiotic prophylaxis in inguinal hernia repair. Surg Gynecol Obstet. 1992;175(6):569-70.
13. Taylor EW, Byrne DJ, Leaper DJ, Karran SJ, Browne MK, Mitchell KJ. Antibiotic prophylaxis and open groin hernia repair. World J Surg. 1997;21(8):811-4; discussion 814-5.
14. Yerdel MA, Akin EB, Dolalan S, Turkcapar AG, Pehlivan M, Gecim IE, Kuterdem E. Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial. Ann Surg. 2001;233(1):26-33.
15. Aufenacker TJ, van Geldere D, van Mesdag T, Bossers AN, Dekker B, Scheijde E, van Nieuwenhuizen R, Hiemstra E, Maduro JH, et al. The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial. Ann Surg. 2004;240(6):955-60; discussion 960-1.
16. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607-12.
17. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project Endocr Pract. 2004;10 Suppl 2:21-33.
18. Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg. 1998;133(4):378-82.
19. Negro P, D'Amore L, Gossetti F, Proposito D, Carboni M. Late infection after mesh-plug inguinal hernioplasty. AmJ Surg. 2002;183(5):603.
20. Crespi G, Giannetta E, Mariani F, Floris F, Pretolesi F, Marino P. Imaging of early postoperative complications after polypropylene mesh repair of inguinal hernia. Radiol Med (Torino). 2004;108(1-2):107-15.
21. Furtschegger A, Sandbichler P, Judmaier W, Gstir H, Steiner E, Egender G. Sonography in the postoperative evaluation of laparoscopic inguinal hernia repair. J Ultrasound Med. 1995;14(9):679-84.
22. Kercher KW, Sing RF, Matthews BD, Heniford BT. Successful salvage of infected PTFE mesh after ventral hernia repair. Ostomy Wound Manage. 2002;48(10):40-2, 44-5.
23. Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop. 1996(332):184-9.
24. NIH consensus conference: Total hip replacement. NIH Consensus Development Panel on Total Hip Replacement. Jama. 1995;273(24):1950-6.
25. Moran CG, Horton TC.Total knee replacement: the joint of the decade. A successful operation, for which there's a large unmet need. BMJ. 2000;320(7238):820.
26. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645-54.
27. Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection. 2004;32(4):222-8.
28. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med. 2004;117(8):556-62.
29. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998;36(10):2932-9.
30. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81(5):672-83.
31. Trampuz A, Steckelberg JM, Osmon DR, Cockerill F, Hanssen AD, Patel R. Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol. 2003;14:1-14.
32. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38(12):1706-15.
33. Tobin EH. Prosthetic joint infections: controversies and clues. Lancet. 1999;353(9155):770-1.
34. Wahl MJ. Myths of dental-induced prosthetic joint infections. Clin Infect Dis. 1995;20(5):1420-5.
35. Eskinazi D, Rathbun W. Is systematic antimicrobial prophylaxis justified in dental patients with prosthetic joints? Oral Surg Oral Med Oral Pathol. 1988;66(4):430-1.
36. Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc. 2003;134(7):895-9.
37. Simmons NA, Ball AP, Cawson RA, Eykyn SJ, Hughes SP, McGowan DA, Shanson DC. Case against antibiotic prophylaxis for dental treatment of patients with joint prostheses. Lancet. 1992;339(8788):301.
38. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279(19):1537-41.
39. Bondurant CP, Jimenez DF. Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg. 1995;23(5):254-8; discussion 259.
40. Bayston R. Infections in hydrocephalus shunts. In: Cohen and Powderly, editors. Infectious diseases. 2nd ed. St. Louis, MO: Elsevier; 2004. p. 317-20.
41. McClinton D, Carraccio C, Englander R. Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J. 2001;20(6):593-7.
42. Kanev PM, Sheehan JM. Reflections on shunt infection. Pediatr Neurosurg. 2003;39(6):285-90.
43. George R, Leibrock L, Epstein M. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg. 1979;51(6):804-11.
44. Aucoin PJ, Kotilainen HR, Gantz NM, Davidson R, Kellogg P, Stone B. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med. 1986;80(3):369-76.
45. Morris A, Low DE. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am. 1999;13(3):735-50.
46. Jacobs DG, Westerband A. Antibiotic prophylaxis for intracranial pressure monitors. J Natl Med Assoc. 1998;90(7):417-23.
47. Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery. 1994;34(1):87-92.
48. Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis. 1993;17(1):98-103.
49. Kohnen W, Kolbenschlag C, Teske-Keiser S, Jansen B. Development of a long-lasting ventricular catheter impregnated with a combination of antibiotics. Biomaterials. 2003;24(26):4865-9.
50. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J. 2002;21(7):632-6.
51. Wooltorton E. Cochlear implant recipients at risk for meningitis. CMAJ. 2002;167(6):670.
52. Telian SA, El-Kashlan HK, Arts HA. Minimizing wound complications in cochlear implant surgery. Am J Otol. 1999;20(3):331-4.
53. Cohen NL, Hoffman RA. Complications of cochlear implant surgery in adults and children. Ann Otol Rhinol Laryngol. 1991;100(9 Pt 1):708-11.
54. Hoffman RA, Cohen NL. Complications of cochlear implant surgery. Ann Otol Rhinol Laryngol Suppl. 1995;166:420-2.
55. Cochlear implant recipients may be at greater risk for meningitis. August 29, 2002. http://www.fda.gov/ cdrh/safety/cochlear.html.
56. Use of vaccines for the prevention of meningitis in persons with cochlear implants. July 30, 2003. www.cdc.gov/nip/issues/cochlear/cochlear-gen.htm.
57. Yu KC, Hegarty JL, Gantz BJ, Lalwani AK. Conservative management of infections in cochlear implant recipients. Otolaryngol Head Neck Surg. 2001;125(1):66-70.
58. Basavaraj S, Najaraj S, Shanks M, Wardrop P, Allen AA. Short-term versus long-term antibiotic prophylaxis in cochlear implant surgery. Otol Neurotol. 2004;25(5):720-2.
59. Robinson PJ, Chopra S. Antibiotic prophylaxis in cochlear implantation: current practice. J Laryngol Otol Suppl. 1989;18:20-1.
60. Rubinstein JT, Gantz BJ, Parkinson WS. Management of cochlear implant infections. Am J Otol. 1999;20(1):46-9.
61. Branemark PI, Adell R, Breine U, Hansson BO, Lindstrom J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3(2):81-100.
62. Wood MR, Vermilyea SG. A review of selected dental literature on evidence-based treatment planning for dental implants: report of the Committee on Research in Fixed Prosthodontics of the Academy of Fixed Prosthodontics. J Prosthet Dent. 2004;92(5):447-62.
63. Chen S, Darby I. Dental implants: maintenance, care and treatment of peri-implant infection. Aust Dent J. 2003;48(4):212-20; quiz 263.
64. Buser D, Mericske-Stern R, Bernard JP, Behneke A, Behneke N, Hirt HP, Belser UC, Lang NP. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multicenter study with 2359 implants. Clin Oral Implants Res. 1997;8(3):161-72.
65. Heydenrijk K, Meijer HJ, van der Reijden WA, Raghoebar GM, Vissink A, Stegenga B. Microbiota around root-form endosseous implants: a review of the literature. Int J Oral Maxillofac Implants. 2002;17(6):829-38.
66. Dent CD, Olson JW, Farish SE, Bellome J, Casino AJ, Morris HF, Ochi S. The influence of preoperative antibiotics on success of endosseous implants up to and including stage II surgery: a study of 2,641 implants. J Oral Maxillofac Surg. 1997;55(12 Suppl 5):19-24.
67. Laskin DM, Dent CD, Morris HF, Ochi S, Olson JW. The influence of preoperative antibiotics on success of endosseous implants at 36 months. Ann Periodontol. 2000;5(1):166-74.
68. Gynther GW, Kondell PA, Moberg LE, Heimdahl A. Dental implant installation without antibiotic prophylaxis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(5):509-11.
69. Carson CC. Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res. 2003;15 Suppl 5:S139-46.
70. Henry GD, Wilson SK, Delk JR, 2nd, Carson CC, Wiygul J, Tornehl C, Cleves MA, Silverstein A, Donatucci CF. Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study. J Urol. 2005;173(1):89-92.
71. Montague DK, Angermeier KW, Lakin MM. Penile prosthesis infections. Int J Impot Res. 2001;13(6):326-8.
72. Henry GD, Wilson SK, Delk JR, 2nd, Carson CC, Silverstein A, Cleves MA, Donatucci CF. Penile prosthesis cultures during revision surgery: a multicenter study. J Urol. 2004;172(1):153-6.
73. Moncada I, Jara J, Cabello R, Monzo JI, Hernandez C. Radiological assessment of penile prosthesis: the role of magnetic resonance imaging. World J Urol. 2004.
74. Carson CC 3rd. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol. 2004;171(4):1611-4.
75. Small MP. Small-Carrion penile prosthesis: a report on 160 cases and review of the literature. J Urol. 1978;119(3):365-8.
76. Grabe M, Forsgren A. Impact of short perioperative courses of cefotaxime on aerobic bacterial flora in patients undergoing transurethral prostatic resection. Eur J Clin Microbiol. 1985;4(1):24-9.
77. Mulcahy JJ. Treatment alternatives for the infected penile implant. Int J Impot Res. 2003;15 Suppl 5:S147-9.
78. Brant MD, Ludlow JK, Mulcahy JJ. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J Urol. 1996;155(1):155-7.
79. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd. Complications leading to surgery after breast implantation. N Engl J Med. 1997;336(10):677-82.
80. Handel N, Jensen JA, Black Q, Waisman JR, Silverstein MJ. The fate of breast implants: a critical analysis of complications and outcomes. Plast Reconstr Surg. 1995;96(7):1521-33.
81. Armstrong RW, Berkowitz RL, Bolding F. Infection following breast reconstruction. Ann Plast Surg. 1989;23(4):284-8.
82. Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112(2):467-76.
83. Ahn CY, Ko CY, Wagar EA, Wong RS, Shaw WW. Microbial evaluation: 139 implants removed from symptomatic patients. Plast Reconstr Surg. 1996;98(7):1225-9.
84. Darouiche RO, Meade R, Mansouri MD, Netscher DT. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast Reconstr Surg. 2002;109(4):1352-7.
85. Hall JC, Hall JL. Antibiotic prophylaxis for patients undergoing breast surgery. J Hosp Infect. 2000;46(3):165-70.
86. Spear SL, Howard MA, Boehmler JH, Ducic I, Low M, Abbruzzesse MR. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg. 2004;113(6):1634-44.
87. Yii NW, Khoo CT. Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg. 2003;111(3):1087-92.